Targeting mediators of Wnt signalling pathways by GnRH in gonadotropes

Journal of Molecular Endocrinology

Volumn 44, Issue 4, 2010, Pages 195-201

  Gardner, Samantha ^a,b   Stavrou, Emmanouil ^a   Rischitor, Patricia E ^a   Faccenda, Elena ^a   Pawson, Adam J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; CASEIN KINASE I; DIACYLGLYCEROL; FOLLITROPIN; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GONADORELIN; GONADORELIN RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE; LUTEINIZING HORMONE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C BETA; PROTEIN KINASE C; T CELL FACTOR PROTEIN; WNT PROTEIN;

EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME INHIBITION; GONADOTROPIN SECRETING CELL; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UBIQUITINATION;

ANIMALS; BETA CATENIN; FRIZZLED RECEPTORS; GLYCOGEN SYNTHASE KINASE 3; GONADOTROPHS; GONADOTROPIN-RELEASING HORMONE; HUMANS; RECEPTORS, LHRH; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 77950258705     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-09-0168     Document Type: Review

References (71)

1. Angel P, Hattori K, Smeal T & KarinM1988 The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55 875-885.
2. 2+/NFAT signaling pathway decode GnRH pulse frequency? Journal of Biological Chemistry 284 35746-35757.
3. Burger LL, Haisenleder DJ, Wotton GM, Aylor KW, Dalkin AC & Marshall JC 2007 The regulation of FSHβ transcription by gonadal steroids: testosterone and estradiol modulation of the activin intracellular signaling pathway. American Journal of Physiology. Endocrinology and Metabolism 293 E277-E285.
4. Caunt CJ, Finch AR, Sedgley KR & McArdle CA 2006 GnRH receptor signalling to ERK: kinetics and compartmentalization. Trends in Endocrinology and Metabolism 17 308-313.
5. Cheng KW & Leung PC 2001 Human gonadotropin-releasing hormone receptor gene transcription: up-regulation by 3′,5′-cyclic adenosine monophosphate/protein kinase A pathway. Molecular and Cellular Endocrinology 181 15-26.
6. Chesire DR & Isaacs WB 2003 β-Catenin signaling in prostate cancer: an early perspective. Endocrine-Related Cancer 10 537-560.
7. Cook D, Fry MJ, Hughes K, Sumathipala R, Woodgett JR & Dale TC 1996 Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO Journal 15 4526-4536.
8. Crabtree GR & Olson EN 2002 NFAT signaling: choreographing the social lives of cells. Cell 109 S67-S79.
9. Curtin D, Jenkins S, Farmer N, Anderson AC, Haisenleder DJ, Rissman E, Wilson EM & Shupnik MA 2001 Androgen suppression of GnRH-stimulated rat LHβ gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region. Molecular Endocrinology 15 1906-1917.
10. Curtin D, Ferris HA, Hakli M, Gibson M, Janne OA, Palvimo JJ & Shupnik MA 2004 Small nuclear RING finger protein stimulates the rat luteinizing hormone-β promoter by interacting with Sp1 and steroidogenic factor-1 and protects from androgen suppression. Molecular Endocrinology 18 1263-1276.
11. Desclozeaux M, Krylova IN, Horn F, Fletterick RJ & Ingraham HA 2002 Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Molecular and Cellular Biology 22 7193-7203.
12. Ding VW, Chen RH & McCormick F 2000 Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling. Journal of Biological Chemistry 275 32475-32481.
13. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z et al. 2005 Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin. Molecules and Cells 19 159-170.
14. Dobkin-Bekman M, Naidich M, Pawson AJ, Millar RP, Seger R & Naor Z 2006 Activation of mitogen-activated protein kinase (MAPK) by GnRH is cell-context dependent. Molecular and Cellular Endocrinology 252 184-190.
15. Doble BW & Woodgett JR 2003 GSK-3: tricks of the trade for a multitasking kinase. Journal of Cell Science 116 1175-1186.
16. van Es JH, Barker N & Clevers H 2003 You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Current Opinion in Genetics and Development 13 28-33.
17. Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM & Korswagen HC 2005 Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science 308 1181-1184.
18. Farias GG, Godoy JA, Hernandez F, Avila J, Fisher A & Inestrosa NC 2004 M1 muscarinic receptor activation protects neurons from β-amyloid toxicity. A role for Wnt signaling pathway. Neurobiology of Disease 17 337-348.
19. Frame S & Cohen P 2001 GSK3 takes centre stage more than 20 years after its discovery. Biochemical Journal 359 1-16.
20. Fujino H & Regan JW 2001 FP prostanoid receptor activation of a T-cell factor/β-catenin signaling pathway. Journal of Biological Chemistry 276 12489-12492.
21. 2. Journal of Biological Chemistry 277 2614-2619.
22. Gardner S & Pawson AJ 2009 Emerging targets of the GnRH receptor: novel interactions with Wnt signalling mediators. Neuroendocrinology 89 241-251.
23. Gardner S, Maudsley S, Millar RP & Pawson AJ 2007 Nuclear stabilization of β-catenin and inactivation of glycogen synthase kinase-3β by gonadotropin-releasing hormone: targeting Wnt signaling in the pituitary gonadotrope. Molecular Endocrinology 21 3028-3038.
24. Grimes CA & Jope RS 2001 The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Progress in Neurobiology 65 391-426.
25. Gummow BM, Winnay JN & Hammer GD 2003 Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. Journal of Biological Chemistry 278 26572-26579.
26. Hoogeboom D & Burgering BM 2009 Should I stay or should I go: b-catenin decides under stress. Biochimica et Biophysica Acta 1796 63-74.
27. Hoogeboom D, Essers MA, Polderman PE, Voets E, Smits LM & Burgering BM 2008 Interaction of FOXO with β-catenin inhibits β-catenin/T cell factor activity. Journal of Biological Chemistry 283 9224-9230.
28. Huelsken J & Behrens J 2002 The Wnt signalling pathway. Journal of Cell Science 115 3977-3978.
29. Jin T, George Fantus I & Sun J 2008 Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of β-catenin. Cellular Signalling 20 1697-1704.
30. Jorgensen JS & Nilson JH 2001a AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein- protein interactions with cJun and activation transcription factor 2. Molecular Endocrinology 15 1496-1504.
31. Jorgensen JS & Nilson JH 2001b AR suppresses transcription of the LHb subunit by interacting with steroidogenic factor-1. Molecular Endocrinology 15 1505-1516.
32. Katoh M & Katoh M 2007 WNT signaling pathway and stem cell signaling network. Clinical Cancer Research 13 4042-4045.
33. Kohn AD & Moon RT 2005 Wnt and calcium signaling: β-cateninindependent pathways. Cell Calcium 38 439-446.
34. 2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends in Genetics 16 279-283.
35. Le Floch N, Rivat C, De Wever O, Bruyneel E, Mareel M, Dale T & Gespach C 2005 The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3β and c-Jun/AP-1 signaling. FASEB Journal 19 144-146.
36. Lim S, Luo M, Koh M, Yang M, bin Abdul Kadir MN, Tan JH, Ye Z, Wang W & Melamed P 2007 Distinct mechanisms involving diverse histone deacetylases repress expression of the two gonadotropin β-subunit genes in immature gonadotropes, and their actions are overcome by gonadotropin-releasing hormone. Molecular and Cellular Biology 27 4105-4120.
37. Liu X, Liu T, Slusarski DC, Yang-Snyder J, Malbon CC, Moon RT & Wang H 1999 Activation of a frizzled-2/β-adrenergic receptor chimera promotes Wnt signaling and differentiation of mouse F9 teratocarcinoma cells via Galphao and Galphat. PNAS 96 14383-14388.
38. Liu T, DeCostanzo AJ, Liu X, Wang H, Hallagan S, Moon RT & Malbon CC 2001 G protein signaling from activated rat frizzled-1 to the β-catenin-Lef-Tcf pathway. Science 292 1718-1722.
39. Malbon CC 2005 β-Catenin, cancer, and G proteins: not just for frizzleds anymore. Science's STKE 2005 pe35.
40. Maya-Nunez G & Conn PM 2001 Cyclic adenosine 3′,5′- monophosphate (cAMP) and cAMP responsive element-binding protein are involved in the transcriptional regulation of gonadotropinreleasing hormone (GnRH) receptor by GnRH and mitogenactivated protein kinase signal transduction pathway in GGH(3) cells. Biology of Reproduction 65 561-567.
41. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R & Alessi DR 2005 Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO Journal 24 1571-1583.
42. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K & Maudsley SR 2004 Gonadotropin-releasing hormone receptors. Endocrine Reviews 25 235-275.
43. Millar RP, Pawson AJ, Morgan K, Rissman EF & Lu ZL 2008 Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Frontiers in Neuroendocrinology 29 17-35.
44. Mizusaki H, Kawabe K, Mukai T, Ariyoshi E, Kasahara M, Yoshioka H, Swain A & Morohashi K 2003 Dax-1 (dosagesensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad. Molecular Endocrinology 17 507-519.
45. Moon RT, Kohn AD, De Ferrari GV & Kaykas A 2004 WNT and β-catenin signalling: diseases and therapies. Nature Reviews. Genetics 5 691-701.
46. Mulholland DJ, Dedhar S, Coetzee GA & Nelson CC 2005 Interaction of nuclear receptors with the Wnt/β-catenin/Tcf signaling axis: Wnt you like to know? Endocrine Reviews 26 898-915.
47. 2+ and protein kinase C. European Journal of Endocrinology 136 123-127.
48. Naor Z 2009 Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor. Frontiers in Neuroendocrinology 30 10-29.
49. Naor Z, Benard O & Seger R 2000 Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends in Endocrinology and Metabolism 11 91-99.
50. Nateri AS, Spencer-Dene B & Behrens A 2005 Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 437 281-285.
51. Nelson WJ & Nusse R 2004 Convergence of Wnt, β-catenin, and cadherin pathways. Science 303 1483-1487.
52. Ng SS, Mahmoudi T, Danenberg E, Bejaoui I, de Lau W, Korswagen HC, Schutte M & Clevers H 2009 Phosphatidylinositol 3-kinase (PI3K) signaling does not activate the Wnt cascade. Journal of Biological Chemistry 284 35308-35313.
53. Parakh TN, Hernandez JA, Grammer JC, Weck J, Hunzicker-Dunn M, Zeleznik AJ & Nilson JH 2006 Follicle-stimulating hormone/cAMP regulation of aromatase gene expression requires β-catenin. PNAS 103 12435-12440.
54. Pawson AJ & McNeilly AS 2005 The pituitary effects of GnRH. Animal Reproduction Science 88 75-94.
55. Polakis P 2000 Wnt signaling and cancer. Genes and Development 14 1837-1851.
56. Robinson DR, Zylstra CR & Williams BO 2008 Wnt signaling and prostate cancer. Current Drug Targets 9 571-580.
57. Salisbury TB, Binder AK, Grammer JC & Nilson JH 2007 Maximal activity of the luteinizing hormone b-subunit gene requires β-catenin. Molecular Endocrinology 21 963-971.
58. Salisbury TB, Binder AK & Nilson JH 2008 Welcoming β-catenin to the gonadotropin-releasing hormone transcriptional network in gonadotropes. Molecular Endocrinology 22 1295-1303.
59. Salisbury TB, Binder AK, Grammer JC & Nilson JH 2009 GnRH-regulated expression of Jun and JUN target genes in gonadotropes requires a functional interaction between TCF/LEF family members and β-catenin. Molecular Endocrinology 23 402-411.
60. Schulte G & Bryja V 2007 The Frizzled family of unconventional G-protein-coupled receptors. Trends in Pharmacological Sciences 28 518-525.
61. Shah S, Pishvaian MJ, Easwaran V, Brown PH & Byers SW 2002 The role of cadherin, β-catenin, and AP-1 in retinoid-regulated carcinoma cell differentiation and proliferation. Journal of Biological Chemistry 277 25313-25322.
62. Spady TJ, Shayya R, Thackray VG, Ehrensberger L, Bailey JS & Mellon PL 2004 Androgen regulates follicle-stimulating hormone β gene expression in an activin-dependent manner in immortalized gonadotropes. Molecular Endocrinology 18 925-940.
63. Stambolic V & Woodgett JR 1994 Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation. Biochemical Journal 303 701-704.
64. Stavrou E, Millar RP & Pawson AJ 2009 GnRH regulation of FoxO transcription factors. Society for Endocrinology BES 2009, Harrogate, UK. Endocrine Abstracts 19 P110.
65. Terry S, Yang X, Chen MW, Vacherot F & Buttyan R 2006 Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. Journal of Cellular Biochemistry 99 402-410.
66. Thackray VG & Mellon PL 2008 Synergistic induction of folliclestimulating hormone β-subunit gene expression by gonadal steroid hormone receptors and Smad proteins. Endocrinology 149 1091-1102.
67. Thackray VG, McGillivray SM & Mellon PL 2006 Androgens, progestins, and glucocorticoids induce follicle-stimulating hormone β-subunit gene expression at the level of the gonadotrope. Molecular Endocrinology 20 2062-2079.
68. Thomas GM, Frame S, Goedert M, Nathke I, Polakis P & Cohen P 1999 A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and β-catenin. FEBS Letters 458 247-251.
69. Veeman MT, Axelrod JD & Moon RT 2003 A second canon. Functions and mechanisms of β-catenin-independent Wnt signaling. Developmental Cell 5 367-377.
70. Yan W & Tai HH 2006 Glycogen synthase kinase-3 phosphorylation, T-cell factor signaling activation, and cell morphology change following stimulation of thromboxane receptor α. Journal of Pharmacological and Experimental Therapeutics 317 267-274.
71. Yang M, Zhong WW, Srivastava N, Slavin A, Yang J, Hoey T & An S 2005 G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the β-catenin pathway. PNAS 102 6027-6032.